Describing drivers of and barriers to persistence with tiotropium in patients with chronic obstructive pulmonary disease: A mixed-methods approach
Objective: To understand the factors influencing persistence with tiotropium in patients with chronic obstructive pulmonary disease (COPD).
Methods: Patients classified as 'persistent' or 'non-persistent' with tiotropium were identified from pharmacy dispensing records. Patients were compared for health status, beliefs and behaviours using data from questionnaires and interviews.
Key findings: Perceptions of the risks and benefits of medication, fear of worsening illness, and the GP's emphasis on the importance of the medication were key determinants of tiotropium persistence
.Conclusions: Perceptions, attitudes and beliefs of patients and doctors influence persistence with tiotropium. These complex interactions need to be targeted to improve persistence with medicines in COPD.
History
Publication title
International Journal of Pharmacy PracticeVolume
32Pagination
154-157ISSN
0961-7671Department/School
School of Pharmacy and PharmacologyPublisher
John Wiley & Sons Ltd.Place of publication
United KingdomRights statement
Copyright 2014 Royal Pharmaceutical SocietyRepository Status
- Restricted